nodes	percent_of_prediction	percent_of_DWPC	metapath
Bromocriptine—HTR1D—meninx—Behcet's disease	0.137	0.143	CbGeAlD
Bromocriptine—HTR7—pulmonary artery—Behcet's disease	0.0429	0.0449	CbGeAlD
Bromocriptine—HTR7—vein—Behcet's disease	0.0391	0.0409	CbGeAlD
Bromocriptine—HTR7—pons—Behcet's disease	0.0305	0.0318	CbGeAlD
Bromocriptine—HTR2A—pulmonary artery—Behcet's disease	0.0268	0.028	CbGeAlD
Bromocriptine—HTR2A—vein—Behcet's disease	0.0244	0.0255	CbGeAlD
Bromocriptine—HTR1B—artery—Behcet's disease	0.0206	0.0216	CbGeAlD
Bromocriptine—HTR1D—artery—Behcet's disease	0.02	0.0209	CbGeAlD
Bromocriptine—HTR2A—pons—Behcet's disease	0.019	0.0199	CbGeAlD
Bromocriptine—HTR1B—blood vessel—Behcet's disease	0.0161	0.0168	CbGeAlD
Bromocriptine—HTR7—artery—Behcet's disease	0.0159	0.0166	CbGeAlD
Bromocriptine—HTR1D—blood vessel—Behcet's disease	0.0156	0.0163	CbGeAlD
Bromocriptine—HTR7—endothelium—Behcet's disease	0.0134	0.0141	CbGeAlD
Bromocriptine—HTR7—blood vessel—Behcet's disease	0.0124	0.013	CbGeAlD
Bromocriptine—DRD1—brainstem—Behcet's disease	0.0109	0.0113	CbGeAlD
Bromocriptine—HTR7—mouth—Behcet's disease	0.0104	0.0109	CbGeAlD
Bromocriptine—HTR2A—artery—Behcet's disease	0.00993	0.0104	CbGeAlD
Bromocriptine—HTR1B—brainstem—Behcet's disease	0.00879	0.00919	CbGeAlD
Bromocriptine—DRD4—brain—Behcet's disease	0.00863	0.00903	CbGeAlD
Bromocriptine—HTR1D—brainstem—Behcet's disease	0.00851	0.0089	CbGeAlD
Bromocriptine—HTR2C—brainstem—Behcet's disease	0.00843	0.00881	CbGeAlD
Bromocriptine—HTR2A—endothelium—Behcet's disease	0.00839	0.00877	CbGeAlD
Bromocriptine—HTR1D—eye—Behcet's disease	0.00829	0.00866	CbGeAlD
Bromocriptine—DRD3—nervous system—Behcet's disease	0.00794	0.0083	CbGeAlD
Bromocriptine—HTR2A—blood vessel—Behcet's disease	0.00773	0.00809	CbGeAlD
Bromocriptine—DRD3—central nervous system—Behcet's disease	0.00764	0.00799	CbGeAlD
Bromocriptine—HTR6—nervous system—Behcet's disease	0.00764	0.00799	CbGeAlD
Bromocriptine—DRD5—nervous system—Behcet's disease	0.00744	0.00778	CbGeAlD
Bromocriptine—HTR6—central nervous system—Behcet's disease	0.00736	0.00769	CbGeAlD
Bromocriptine—DRD5—central nervous system—Behcet's disease	0.00716	0.00749	CbGeAlD
Bromocriptine—HTR1A—brainstem—Behcet's disease	0.00709	0.00742	CbGeAlD
Bromocriptine—DRD1—midbrain—Behcet's disease	0.00691	0.00723	CbGeAlD
Bromocriptine—HTR7—brainstem—Behcet's disease	0.00678	0.00709	CbGeAlD
Bromocriptine—HTR2B—skin of body—Behcet's disease	0.00671	0.00701	CbGeAlD
Bromocriptine—ADRA1A—brainstem—Behcet's disease	0.00654	0.00684	CbGeAlD
Bromocriptine—DRD2—brainstem—Behcet's disease	0.00641	0.0067	CbGeAlD
Bromocriptine—DRD2—eye—Behcet's disease	0.00624	0.00652	CbGeAlD
Bromocriptine—DRD2—retina—Behcet's disease	0.00618	0.00647	CbGeAlD
Bromocriptine—ADRB1—cardiac atrium—Behcet's disease	0.00612	0.0064	CbGeAlD
Bromocriptine—ADRA1B—nervous system—Behcet's disease	0.0061	0.00638	CbGeAlD
Bromocriptine—DRD3—brain—Behcet's disease	0.00607	0.00634	CbGeAlD
Bromocriptine—ADRA1D—nervous system—Behcet's disease	0.00597	0.00624	CbGeAlD
Bromocriptine—HTR2C—medulla oblongata—Behcet's disease	0.00588	0.00615	CbGeAlD
Bromocriptine—ADRA1B—central nervous system—Behcet's disease	0.00587	0.00614	CbGeAlD
Bromocriptine—HTR6—brain—Behcet's disease	0.00584	0.00611	CbGeAlD
Bromocriptine—ADRA1D—central nervous system—Behcet's disease	0.00574	0.00601	CbGeAlD
Bromocriptine—DRD5—brain—Behcet's disease	0.00569	0.00595	CbGeAlD
Bromocriptine—DRD1—nervous system—Behcet's disease	0.00568	0.00594	CbGeAlD
Bromocriptine—HTR1B—midbrain—Behcet's disease	0.0056	0.00586	CbGeAlD
Bromocriptine—DRD1—central nervous system—Behcet's disease	0.00547	0.00572	CbGeAlD
Bromocriptine—HTR1B—spinal cord—Behcet's disease	0.00547	0.00572	CbGeAlD
Bromocriptine—HTR1D—midbrain—Behcet's disease	0.00542	0.00567	CbGeAlD
Bromocriptine—HTR2C—midbrain—Behcet's disease	0.00537	0.00562	CbGeAlD
Bromocriptine—HTR2C—spinal cord—Behcet's disease	0.00524	0.00548	CbGeAlD
Bromocriptine—ABCB1—blood vessel—Behcet's disease	0.00507	0.0053	CbGeAlD
Bromocriptine—ADRA2C—mammalian vulva—Behcet's disease	0.00481	0.00503	CbGeAlD
Bromocriptine—HTR7—medulla oblongata—Behcet's disease	0.00473	0.00494	CbGeAlD
Bromocriptine—ADRA1B—brain—Behcet's disease	0.00466	0.00487	CbGeAlD
Bromocriptine—ADRA2C—cardiac atrium—Behcet's disease	0.00461	0.00482	CbGeAlD
Bromocriptine—HTR1B—nervous system—Behcet's disease	0.00461	0.00482	CbGeAlD
Bromocriptine—ADRA1D—brain—Behcet's disease	0.00456	0.00477	CbGeAlD
Bromocriptine—HTR1A—midbrain—Behcet's disease	0.00452	0.00473	CbGeAlD
Bromocriptine—HTR1D—nervous system—Behcet's disease	0.00446	0.00466	CbGeAlD
Bromocriptine—HTR1B—central nervous system—Behcet's disease	0.00443	0.00464	CbGeAlD
Bromocriptine—HTR2C—nervous system—Behcet's disease	0.00442	0.00462	CbGeAlD
Bromocriptine—HTR1A—spinal cord—Behcet's disease	0.00441	0.00461	CbGeAlD
Bromocriptine—ADRA2C—medulla oblongata—Behcet's disease	0.00435	0.00454	CbGeAlD
Bromocriptine—DRD1—brain—Behcet's disease	0.00435	0.00454	CbGeAlD
Bromocriptine—ADRB1—nervous system—Behcet's disease	0.00433	0.00453	CbGeAlD
Bromocriptine—HTR7—midbrain—Behcet's disease	0.00432	0.00452	CbGeAlD
Bromocriptine—HTR1D—central nervous system—Behcet's disease	0.00429	0.00449	CbGeAlD
Bromocriptine—HTR2C—central nervous system—Behcet's disease	0.00425	0.00445	CbGeAlD
Bromocriptine—HTR2A—brainstem—Behcet's disease	0.00423	0.00442	CbGeAlD
Bromocriptine—HTR7—spinal cord—Behcet's disease	0.00422	0.00441	CbGeAlD
Bromocriptine—ADRB1—central nervous system—Behcet's disease	0.00417	0.00436	CbGeAlD
Bromocriptine—HTR2B—nervous system—Behcet's disease	0.00415	0.00434	CbGeAlD
Bromocriptine—HTR2A—eye—Behcet's disease	0.00412	0.0043	CbGeAlD
Bromocriptine—DRD2—midbrain—Behcet's disease	0.00409	0.00427	CbGeAlD
Bromocriptine—HTR2A—retina—Behcet's disease	0.00408	0.00426	CbGeAlD
Bromocriptine—HTR2B—central nervous system—Behcet's disease	0.00399	0.00418	CbGeAlD
Bromocriptine—ADRA2C—midbrain—Behcet's disease	0.00397	0.00415	CbGeAlD
Bromocriptine—ADRA2C—spinal cord—Behcet's disease	0.00387	0.00405	CbGeAlD
Bromocriptine—ADRA2A—mammalian vulva—Behcet's disease	0.00384	0.00402	CbGeAlD
Bromocriptine—HTR1A—nervous system—Behcet's disease	0.00372	0.00389	CbGeAlD
Bromocriptine—ADRA2A—cardiac atrium—Behcet's disease	0.00368	0.00385	CbGeAlD
Bromocriptine—HTR1A—central nervous system—Behcet's disease	0.00358	0.00374	CbGeAlD
Bromocriptine—HTR7—nervous system—Behcet's disease	0.00355	0.00371	CbGeAlD
Bromocriptine—HTR1B—brain—Behcet's disease	0.00352	0.00368	CbGeAlD
Bromocriptine—ADRA2A—medulla oblongata—Behcet's disease	0.00347	0.00363	CbGeAlD
Bromocriptine—ADRA1A—nervous system—Behcet's disease	0.00343	0.00358	CbGeAlD
Bromocriptine—HTR7—central nervous system—Behcet's disease	0.00342	0.00358	CbGeAlD
Bromocriptine—HTR1D—brain—Behcet's disease	0.00341	0.00356	CbGeAlD
Bromocriptine—HTR2C—brain—Behcet's disease	0.00338	0.00353	CbGeAlD
Bromocriptine—DRD2—nervous system—Behcet's disease	0.00336	0.00351	CbGeAlD
Bromocriptine—ADRB1—brain—Behcet's disease	0.00331	0.00346	CbGeAlD
Bromocriptine—ADRA1A—central nervous system—Behcet's disease	0.0033	0.00345	CbGeAlD
Bromocriptine—ADRA2C—nervous system—Behcet's disease	0.00326	0.00341	CbGeAlD
Bromocriptine—DRD2—central nervous system—Behcet's disease	0.00323	0.00338	CbGeAlD
Bromocriptine—HTR2B—brain—Behcet's disease	0.00317	0.00332	CbGeAlD
Bromocriptine—ADRA2A—midbrain—Behcet's disease	0.00317	0.00331	CbGeAlD
Bromocriptine—ADRA2C—central nervous system—Behcet's disease	0.00314	0.00329	CbGeAlD
Bromocriptine—ADRA2A—spinal cord—Behcet's disease	0.00309	0.00323	CbGeAlD
Bromocriptine—HTR2A—medulla oblongata—Behcet's disease	0.00295	0.00308	CbGeAlD
Bromocriptine—HTR1A—brain—Behcet's disease	0.00284	0.00297	CbGeAlD
Bromocriptine—HTR7—brain—Behcet's disease	0.00272	0.00284	CbGeAlD
Bromocriptine—HTR2A—midbrain—Behcet's disease	0.00269	0.00282	CbGeAlD
Bromocriptine—ABCB1—retina—Behcet's disease	0.00267	0.00279	CbGeAlD
Bromocriptine—HTR2A—spinal cord—Behcet's disease	0.00263	0.00275	CbGeAlD
Bromocriptine—ADRA1A—brain—Behcet's disease	0.00262	0.00274	CbGeAlD
Bromocriptine—ADRA2A—nervous system—Behcet's disease	0.00261	0.00272	CbGeAlD
Bromocriptine—DRD2—brain—Behcet's disease	0.00257	0.00268	CbGeAlD
Bromocriptine—ADRA2A—central nervous system—Behcet's disease	0.00251	0.00262	CbGeAlD
Bromocriptine—ADRA2C—brain—Behcet's disease	0.0025	0.00261	CbGeAlD
Bromocriptine—HTR2A—nervous system—Behcet's disease	0.00222	0.00232	CbGeAlD
Bromocriptine—ABCB1—mammalian vulva—Behcet's disease	0.00214	0.00224	CbGeAlD
Bromocriptine—HTR2A—central nervous system—Behcet's disease	0.00213	0.00223	CbGeAlD
Bromocriptine—CYP3A4—nervous system—Behcet's disease	0.00205	0.00214	CbGeAlD
Bromocriptine—ADRA2A—brain—Behcet's disease	0.00199	0.00208	CbGeAlD
Bromocriptine—CYP3A4—central nervous system—Behcet's disease	0.00197	0.00206	CbGeAlD
Bromocriptine—ABCB1—medulla oblongata—Behcet's disease	0.00193	0.00202	CbGeAlD
Bromocriptine—ABCB1—midbrain—Behcet's disease	0.00177	0.00185	CbGeAlD
Bromocriptine—ABCB1—spinal cord—Behcet's disease	0.00172	0.0018	CbGeAlD
Bromocriptine—HTR2A—brain—Behcet's disease	0.00169	0.00177	CbGeAlD
Bromocriptine—ABCB1—nervous system—Behcet's disease	0.00145	0.00152	CbGeAlD
Bromocriptine—ABCB1—central nervous system—Behcet's disease	0.0014	0.00146	CbGeAlD
Bromocriptine—ABCB1—brain—Behcet's disease	0.00111	0.00116	CbGeAlD
Bromocriptine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—Behcet's disease	9.51e-05	0.00218	CbGpPWpGaD
Bromocriptine—DRD2—Signaling by GPCR—CCR1—Behcet's disease	9.28e-05	0.00213	CbGpPWpGaD
Bromocriptine—HTR6—Class A/1 (Rhodopsin-like receptors)—CXCL8—Behcet's disease	9.17e-05	0.0021	CbGpPWpGaD
Bromocriptine—HTR7—Class A/1 (Rhodopsin-like receptors)—CXCL8—Behcet's disease	9.16e-05	0.0021	CbGpPWpGaD
Bromocriptine—ADRA2A—GPCR downstream signaling—CCR1—Behcet's disease	9.14e-05	0.0021	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling by GPCR—CCR1—Behcet's disease	9.13e-05	0.00209	CbGpPWpGaD
Bromocriptine—HTR1D—Class A/1 (Rhodopsin-like receptors)—CXCL8—Behcet's disease	9.1e-05	0.00209	CbGpPWpGaD
Bromocriptine—DRD5—GPCR ligand binding—CXCL8—Behcet's disease	9.05e-05	0.00208	CbGpPWpGaD
Bromocriptine—ADRA2B—Hemostasis—APOB—Behcet's disease	9e-05	0.00207	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling by GPCR—CCR1—Behcet's disease	8.94e-05	0.00205	CbGpPWpGaD
Bromocriptine—HTR1B—Class A/1 (Rhodopsin-like receptors)—CXCL8—Behcet's disease	8.91e-05	0.00204	CbGpPWpGaD
Bromocriptine—ADRA2B—G alpha (i) signalling events—CXCL8—Behcet's disease	8.84e-05	0.00203	CbGpPWpGaD
Bromocriptine—DRD4—Class A/1 (Rhodopsin-like receptors)—CXCL8—Behcet's disease	8.77e-05	0.00201	CbGpPWpGaD
Bromocriptine—HTR1A—G alpha (i) signalling events—CXCL8—Behcet's disease	8.54e-05	0.00196	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—CCR1—Behcet's disease	8.43e-05	0.00193	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—CCR1—Behcet's disease	8.42e-05	0.00193	CbGpPWpGaD
Bromocriptine—ADRA2C—Hemostasis—APOB—Behcet's disease	8.41e-05	0.00193	CbGpPWpGaD
Bromocriptine—HTR2B—Class A/1 (Rhodopsin-like receptors)—CXCL8—Behcet's disease	8.37e-05	0.00192	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—CCR1—Behcet's disease	8.37e-05	0.00192	CbGpPWpGaD
Bromocriptine—ADRA2A—Platelet activation, signaling and aggregation—SERPINE1—Behcet's disease	8.32e-05	0.00191	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling by GPCR—CCR1—Behcet's disease	8.3e-05	0.00191	CbGpPWpGaD
Bromocriptine—ADRA2C—G alpha (i) signalling events—CXCL8—Behcet's disease	8.26e-05	0.00189	CbGpPWpGaD
Bromocriptine—HTR1A—SIDS Susceptibility Pathways—TNF—Behcet's disease	8.25e-05	0.00189	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—CCR1—Behcet's disease	8.19e-05	0.00188	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—CCR1—Behcet's disease	8.06e-05	0.00185	CbGpPWpGaD
Bromocriptine—DRD1—Class A/1 (Rhodopsin-like receptors)—CXCL8—Behcet's disease	7.89e-05	0.00181	CbGpPWpGaD
Bromocriptine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—CXCL8—Behcet's disease	7.79e-05	0.00179	CbGpPWpGaD
Bromocriptine—DRD3—Class A/1 (Rhodopsin-like receptors)—CXCL8—Behcet's disease	7.79e-05	0.00179	CbGpPWpGaD
Bromocriptine—ABCB1—Allograft Rejection—TNF—Behcet's disease	7.72e-05	0.00177	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—CCR1—Behcet's disease	7.7e-05	0.00177	CbGpPWpGaD
Bromocriptine—DRD2—G alpha (i) signalling events—CXCL8—Behcet's disease	7.5e-05	0.00172	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—CCR1—Behcet's disease	7.26e-05	0.00167	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—CCR1—Behcet's disease	7.16e-05	0.00164	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—CCR1—Behcet's disease	7.16e-05	0.00164	CbGpPWpGaD
Bromocriptine—HTR2A—SIDS Susceptibility Pathways—TNF—Behcet's disease	7.12e-05	0.00163	CbGpPWpGaD
Bromocriptine—ADRA2B—Hemostasis—APOA1—Behcet's disease	7.12e-05	0.00163	CbGpPWpGaD
Bromocriptine—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCL8—Behcet's disease	7.1e-05	0.00163	CbGpPWpGaD
Bromocriptine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—CXCL8—Behcet's disease	7.03e-05	0.00161	CbGpPWpGaD
Bromocriptine—HTR6—GPCR ligand binding—CXCL8—Behcet's disease	6.98e-05	0.0016	CbGpPWpGaD
Bromocriptine—HTR7—GPCR ligand binding—CXCL8—Behcet's disease	6.97e-05	0.0016	CbGpPWpGaD
Bromocriptine—HTR1D—GPCR ligand binding—CXCL8—Behcet's disease	6.93e-05	0.00159	CbGpPWpGaD
Bromocriptine—ADRA2A—Hemostasis—APOB—Behcet's disease	6.83e-05	0.00157	CbGpPWpGaD
Bromocriptine—HTR1A—Class A/1 (Rhodopsin-like receptors)—CXCL8—Behcet's disease	6.79e-05	0.00156	CbGpPWpGaD
Bromocriptine—HTR1B—GPCR ligand binding—CXCL8—Behcet's disease	6.79e-05	0.00156	CbGpPWpGaD
Bromocriptine—HTR2C—Class A/1 (Rhodopsin-like receptors)—CXCL8—Behcet's disease	6.75e-05	0.00155	CbGpPWpGaD
Bromocriptine—ADRA2A—G alpha (i) signalling events—CXCL8—Behcet's disease	6.71e-05	0.00154	CbGpPWpGaD
Bromocriptine—DRD4—GPCR ligand binding—CXCL8—Behcet's disease	6.68e-05	0.00153	CbGpPWpGaD
Bromocriptine—ADRA2C—Hemostasis—APOA1—Behcet's disease	6.65e-05	0.00153	CbGpPWpGaD
Bromocriptine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—CXCL8—Behcet's disease	6.57e-05	0.00151	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—CCR1—Behcet's disease	6.53e-05	0.0015	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—CCR1—Behcet's disease	6.47e-05	0.00148	CbGpPWpGaD
Bromocriptine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CXCL8—Behcet's disease	6.46e-05	0.00148	CbGpPWpGaD
Bromocriptine—HTR2B—GPCR ligand binding—CXCL8—Behcet's disease	6.37e-05	0.00146	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—CCR1—Behcet's disease	6.24e-05	0.00143	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—CCR1—Behcet's disease	6.21e-05	0.00142	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—CCR1—Behcet's disease	6.04e-05	0.00139	CbGpPWpGaD
Bromocriptine—DRD1—GPCR ligand binding—CXCL8—Behcet's disease	6.01e-05	0.00138	CbGpPWpGaD
Bromocriptine—DRD2—Class A/1 (Rhodopsin-like receptors)—CXCL8—Behcet's disease	5.96e-05	0.00137	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—CCR1—Behcet's disease	5.94e-05	0.00136	CbGpPWpGaD
Bromocriptine—ADRA1D—GPCR ligand binding—CXCL8—Behcet's disease	5.93e-05	0.00136	CbGpPWpGaD
Bromocriptine—DRD3—GPCR ligand binding—CXCL8—Behcet's disease	5.93e-05	0.00136	CbGpPWpGaD
Bromocriptine—HTR2A—Class A/1 (Rhodopsin-like receptors)—CXCL8—Behcet's disease	5.86e-05	0.00135	CbGpPWpGaD
Bromocriptine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CXCL8—Behcet's disease	5.74e-05	0.00132	CbGpPWpGaD
Bromocriptine—ADRA2B—Hemostasis—SERPINE1—Behcet's disease	5.65e-05	0.0013	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—CCR1—Behcet's disease	5.48e-05	0.00126	CbGpPWpGaD
Bromocriptine—ADRA2A—Hemostasis—APOA1—Behcet's disease	5.4e-05	0.00124	CbGpPWpGaD
Bromocriptine—ADRB1—GPCR ligand binding—CXCL8—Behcet's disease	5.4e-05	0.00124	CbGpPWpGaD
Bromocriptine—ADRA2B—Hemostasis—NOS3—Behcet's disease	5.4e-05	0.00124	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—CCR1—Behcet's disease	5.39e-05	0.00124	CbGpPWpGaD
Bromocriptine—ADRA2B—GPCR ligand binding—CXCL8—Behcet's disease	5.35e-05	0.00123	CbGpPWpGaD
Bromocriptine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CXCL8—Behcet's disease	5.33e-05	0.00122	CbGpPWpGaD
Bromocriptine—ADRA2C—Hemostasis—SERPINE1—Behcet's disease	5.28e-05	0.00121	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—CCR1—Behcet's disease	5.28e-05	0.00121	CbGpPWpGaD
Bromocriptine—HTR1A—GPCR ligand binding—CXCL8—Behcet's disease	5.17e-05	0.00119	CbGpPWpGaD
Bromocriptine—DRD5—Signaling Pathways—APOB—Behcet's disease	5.16e-05	0.00118	CbGpPWpGaD
Bromocriptine—HTR2C—GPCR ligand binding—CXCL8—Behcet's disease	5.14e-05	0.00118	CbGpPWpGaD
Bromocriptine—DRD5—GPCR downstream signaling—CXCL8—Behcet's disease	5.11e-05	0.00117	CbGpPWpGaD
Bromocriptine—ADRA2C—Hemostasis—NOS3—Behcet's disease	5.04e-05	0.00116	CbGpPWpGaD
Bromocriptine—ADRA2C—GPCR ligand binding—CXCL8—Behcet's disease	5e-05	0.00115	CbGpPWpGaD
Bromocriptine—ADRA1B—GPCR ligand binding—CXCL8—Behcet's disease	4.92e-05	0.00113	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—CCR1—Behcet's disease	4.91e-05	0.00113	CbGpPWpGaD
Bromocriptine—DRD5—Signaling by GPCR—CXCL8—Behcet's disease	4.64e-05	0.00107	CbGpPWpGaD
Bromocriptine—DRD2—GPCR ligand binding—CXCL8—Behcet's disease	4.54e-05	0.00104	CbGpPWpGaD
Bromocriptine—HTR2A—GPCR ligand binding—CXCL8—Behcet's disease	4.47e-05	0.00102	CbGpPWpGaD
Bromocriptine—ADRA1A—GPCR ligand binding—CXCL8—Behcet's disease	4.37e-05	0.001	CbGpPWpGaD
Bromocriptine—ADRA2A—Hemostasis—SERPINE1—Behcet's disease	4.29e-05	0.000984	CbGpPWpGaD
Bromocriptine—ADRA2A—Hemostasis—NOS3—Behcet's disease	4.1e-05	0.000939	CbGpPWpGaD
Bromocriptine—ABCB1—Transmembrane transport of small molecules—APOB—Behcet's disease	4.09e-05	0.000938	CbGpPWpGaD
Bromocriptine—DRD5—Signaling Pathways—APOA1—Behcet's disease	4.08e-05	0.000936	CbGpPWpGaD
Bromocriptine—ADRA2A—GPCR ligand binding—CXCL8—Behcet's disease	4.06e-05	0.000932	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—APOB—Behcet's disease	3.98e-05	0.000913	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—APOB—Behcet's disease	3.98e-05	0.000912	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—APOB—Behcet's disease	3.95e-05	0.000906	CbGpPWpGaD
Bromocriptine—HTR6—GPCR downstream signaling—CXCL8—Behcet's disease	3.95e-05	0.000905	CbGpPWpGaD
Bromocriptine—HTR7—GPCR downstream signaling—CXCL8—Behcet's disease	3.94e-05	0.000904	CbGpPWpGaD
Bromocriptine—HTR1D—GPCR downstream signaling—CXCL8—Behcet's disease	3.92e-05	0.000898	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—APOB—Behcet's disease	3.87e-05	0.000887	CbGpPWpGaD
Bromocriptine—HTR1B—GPCR downstream signaling—CXCL8—Behcet's disease	3.83e-05	0.00088	CbGpPWpGaD
Bromocriptine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Behcet's disease	3.81e-05	0.000875	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—APOB—Behcet's disease	3.81e-05	0.000873	CbGpPWpGaD
Bromocriptine—DRD4—GPCR downstream signaling—CXCL8—Behcet's disease	3.77e-05	0.000866	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—APOB—Behcet's disease	3.63e-05	0.000833	CbGpPWpGaD
Bromocriptine—HTR2B—GPCR downstream signaling—CXCL8—Behcet's disease	3.6e-05	0.000826	CbGpPWpGaD
Bromocriptine—HTR6—Signaling by GPCR—CXCL8—Behcet's disease	3.58e-05	0.000822	CbGpPWpGaD
Bromocriptine—HTR7—Signaling by GPCR—CXCL8—Behcet's disease	3.58e-05	0.000821	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling by GPCR—CXCL8—Behcet's disease	3.56e-05	0.000816	CbGpPWpGaD
Bromocriptine—ADRA2C—Metabolism—CAT—Behcet's disease	3.51e-05	0.000806	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling by GPCR—CXCL8—Behcet's disease	3.48e-05	0.000799	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism of lipids and lipoproteins—APOB—Behcet's disease	3.43e-05	0.000787	CbGpPWpGaD
Bromocriptine—DRD4—Signaling by GPCR—CXCL8—Behcet's disease	3.43e-05	0.000786	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—APOB—Behcet's disease	3.43e-05	0.000786	CbGpPWpGaD
Bromocriptine—ADRA2C—Metabolism—APOB—Behcet's disease	3.41e-05	0.000782	CbGpPWpGaD
Bromocriptine—DRD1—GPCR downstream signaling—CXCL8—Behcet's disease	3.4e-05	0.000779	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—APOB—Behcet's disease	3.38e-05	0.000775	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—APOB—Behcet's disease	3.38e-05	0.000775	CbGpPWpGaD
Bromocriptine—DRD3—GPCR downstream signaling—CXCL8—Behcet's disease	3.35e-05	0.000769	CbGpPWpGaD
Bromocriptine—ADRA1D—GPCR downstream signaling—CXCL8—Behcet's disease	3.35e-05	0.000769	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling by GPCR—CXCL8—Behcet's disease	3.27e-05	0.00075	CbGpPWpGaD
Bromocriptine—DRD5—Signaling Pathways—SERPINE1—Behcet's disease	3.24e-05	0.000743	CbGpPWpGaD
Bromocriptine—ABCB1—Transmembrane transport of small molecules—APOA1—Behcet's disease	3.23e-05	0.000742	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—APOA1—Behcet's disease	3.15e-05	0.000722	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—APOA1—Behcet's disease	3.15e-05	0.000722	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—APOA1—Behcet's disease	3.12e-05	0.000717	CbGpPWpGaD
Bromocriptine—DRD5—Signaling Pathways—NOS3—Behcet's disease	3.09e-05	0.000709	CbGpPWpGaD
Bromocriptine—DRD1—Signaling by GPCR—CXCL8—Behcet's disease	3.08e-05	0.000708	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—APOB—Behcet's disease	3.08e-05	0.000707	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—APOA1—Behcet's disease	3.06e-05	0.000702	CbGpPWpGaD
Bromocriptine—ADRB1—GPCR downstream signaling—CXCL8—Behcet's disease	3.05e-05	0.000701	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—APOB—Behcet's disease	3.05e-05	0.0007	CbGpPWpGaD
Bromocriptine—DRD3—Signaling by GPCR—CXCL8—Behcet's disease	3.04e-05	0.000698	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling by GPCR—CXCL8—Behcet's disease	3.04e-05	0.000698	CbGpPWpGaD
Bromocriptine—ADRA2B—GPCR downstream signaling—CXCL8—Behcet's disease	3.03e-05	0.000694	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—APOA1—Behcet's disease	3.01e-05	0.000691	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—APOB—Behcet's disease	2.95e-05	0.000676	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—APOB—Behcet's disease	2.93e-05	0.000672	CbGpPWpGaD
Bromocriptine—HTR1A—GPCR downstream signaling—CXCL8—Behcet's disease	2.92e-05	0.00067	CbGpPWpGaD
Bromocriptine—HTR2C—GPCR downstream signaling—CXCL8—Behcet's disease	2.91e-05	0.000667	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—APOA1—Behcet's disease	2.87e-05	0.000659	CbGpPWpGaD
Bromocriptine—ADRA2A—Metabolism—CAT—Behcet's disease	2.85e-05	0.000654	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—APOB—Behcet's disease	2.85e-05	0.000654	CbGpPWpGaD
Bromocriptine—ADRA2C—GPCR downstream signaling—CXCL8—Behcet's disease	2.83e-05	0.000648	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—APOB—Behcet's disease	2.81e-05	0.000644	CbGpPWpGaD
Bromocriptine—ADRA1B—GPCR downstream signaling—CXCL8—Behcet's disease	2.78e-05	0.000638	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling by GPCR—CXCL8—Behcet's disease	2.77e-05	0.000636	CbGpPWpGaD
Bromocriptine—ADRA2A—Metabolism—APOB—Behcet's disease	2.77e-05	0.000635	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling by GPCR—CXCL8—Behcet's disease	2.75e-05	0.00063	CbGpPWpGaD
Bromocriptine—DRD5—Signaling Pathways—CXCL8—Behcet's disease	2.74e-05	0.000629	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—Behcet's disease	2.72e-05	0.000623	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—APOA1—Behcet's disease	2.71e-05	0.000622	CbGpPWpGaD
Bromocriptine—ADRA2C—Metabolism—APOA1—Behcet's disease	2.7e-05	0.000619	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—APOA1—Behcet's disease	2.67e-05	0.000614	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—APOA1—Behcet's disease	2.67e-05	0.000614	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling by GPCR—CXCL8—Behcet's disease	2.65e-05	0.000608	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling by GPCR—CXCL8—Behcet's disease	2.64e-05	0.000605	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—APOB—Behcet's disease	2.59e-05	0.000593	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling by GPCR—CXCL8—Behcet's disease	2.57e-05	0.000589	CbGpPWpGaD
Bromocriptine—DRD2—GPCR downstream signaling—CXCL8—Behcet's disease	2.56e-05	0.000588	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—APOB—Behcet's disease	2.55e-05	0.000584	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling by GPCR—CXCL8—Behcet's disease	2.53e-05	0.000579	CbGpPWpGaD
Bromocriptine—HTR2A—GPCR downstream signaling—CXCL8—Behcet's disease	2.52e-05	0.000579	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—SERPINE1—Behcet's disease	2.5e-05	0.000573	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—SERPINE1—Behcet's disease	2.5e-05	0.000573	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—APOB—Behcet's disease	2.49e-05	0.000572	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—SERPINE1—Behcet's disease	2.48e-05	0.000569	CbGpPWpGaD
Bromocriptine—ADRA1A—GPCR downstream signaling—CXCL8—Behcet's disease	2.47e-05	0.000567	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—APOA1—Behcet's disease	2.44e-05	0.000559	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—SERPINE1—Behcet's disease	2.43e-05	0.000557	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—APOA1—Behcet's disease	2.41e-05	0.000554	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—SERPINE1—Behcet's disease	2.39e-05	0.000548	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—NOS3—Behcet's disease	2.39e-05	0.000547	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—NOS3—Behcet's disease	2.38e-05	0.000547	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—NOS3—Behcet's disease	2.37e-05	0.000543	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—APOA1—Behcet's disease	2.33e-05	0.000535	CbGpPWpGaD
Bromocriptine—DRD2—Signaling by GPCR—CXCL8—Behcet's disease	2.33e-05	0.000534	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—NOS3—Behcet's disease	2.32e-05	0.000532	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—APOA1—Behcet's disease	2.32e-05	0.000532	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—APOB—Behcet's disease	2.32e-05	0.000531	CbGpPWpGaD
Bromocriptine—ADRA2A—GPCR downstream signaling—CXCL8—Behcet's disease	2.3e-05	0.000527	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling by GPCR—CXCL8—Behcet's disease	2.29e-05	0.000526	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—NOS3—Behcet's disease	2.28e-05	0.000523	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—SERPINE1—Behcet's disease	2.28e-05	0.000523	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—APOA1—Behcet's disease	2.26e-05	0.000517	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling by GPCR—CXCL8—Behcet's disease	2.24e-05	0.000515	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—APOA1—Behcet's disease	2.22e-05	0.000509	CbGpPWpGaD
Bromocriptine—ADRA2A—Metabolism—APOA1—Behcet's disease	2.19e-05	0.000503	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—NOS3—Behcet's disease	2.18e-05	0.0005	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—SERPINE1—Behcet's disease	2.15e-05	0.000494	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—SERPINE1—Behcet's disease	2.12e-05	0.000487	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—SERPINE1—Behcet's disease	2.12e-05	0.000487	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—CXCL8—Behcet's disease	2.12e-05	0.000486	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—CXCL8—Behcet's disease	2.11e-05	0.000485	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—CXCL8—Behcet's disease	2.1e-05	0.000482	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling by GPCR—CXCL8—Behcet's disease	2.08e-05	0.000478	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—CXCL8—Behcet's disease	2.06e-05	0.000472	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—NOS3—Behcet's disease	2.05e-05	0.000471	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—APOA1—Behcet's disease	2.05e-05	0.000469	CbGpPWpGaD
Bromocriptine—ADRA2C—Metabolism—NOS3—Behcet's disease	2.04e-05	0.000469	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—NOS3—Behcet's disease	2.03e-05	0.000465	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—NOS3—Behcet's disease	2.03e-05	0.000465	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—CXCL8—Behcet's disease	2.02e-05	0.000464	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—APOA1—Behcet's disease	2.01e-05	0.000462	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—CAT—Behcet's disease	1.97e-05	0.000452	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—APOA1—Behcet's disease	1.97e-05	0.000452	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—SERPINE1—Behcet's disease	1.93e-05	0.000444	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—CXCL8—Behcet's disease	1.93e-05	0.000443	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—SERPINE1—Behcet's disease	1.92e-05	0.00044	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—APOB—Behcet's disease	1.91e-05	0.000439	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—SERPINE1—Behcet's disease	1.85e-05	0.000424	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—NOS3—Behcet's disease	1.85e-05	0.000424	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—SERPINE1—Behcet's disease	1.84e-05	0.000422	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—APOA1—Behcet's disease	1.83e-05	0.00042	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—NOS3—Behcet's disease	1.83e-05	0.00042	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—CXCL8—Behcet's disease	1.82e-05	0.000418	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—CXCL8—Behcet's disease	1.8e-05	0.000412	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—CXCL8—Behcet's disease	1.8e-05	0.000412	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—SERPINE1—Behcet's disease	1.79e-05	0.000411	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—NOS3—Behcet's disease	1.77e-05	0.000405	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—SERPINE1—Behcet's disease	1.76e-05	0.000404	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—NOS3—Behcet's disease	1.76e-05	0.000403	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—NOS3—Behcet's disease	1.71e-05	0.000392	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—NOS3—Behcet's disease	1.68e-05	0.000386	CbGpPWpGaD
Bromocriptine—ADRA2A—Metabolism—NOS3—Behcet's disease	1.66e-05	0.000381	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—CXCL8—Behcet's disease	1.64e-05	0.000376	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—SERPINE1—Behcet's disease	1.62e-05	0.000373	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—CXCL8—Behcet's disease	1.62e-05	0.000372	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—SERPINE1—Behcet's disease	1.6e-05	0.000367	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—CAT—Behcet's disease	1.57e-05	0.000361	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—CXCL8—Behcet's disease	1.57e-05	0.000359	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—SERPINE1—Behcet's disease	1.57e-05	0.000359	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—CXCL8—Behcet's disease	1.56e-05	0.000358	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—NOS3—Behcet's disease	1.55e-05	0.000356	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—APOB—Behcet's disease	1.53e-05	0.000351	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—NOS3—Behcet's disease	1.53e-05	0.00035	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—CXCL8—Behcet's disease	1.52e-05	0.000348	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—APOA1—Behcet's disease	1.52e-05	0.000348	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—NOS3—Behcet's disease	1.49e-05	0.000343	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—CXCL8—Behcet's disease	1.49e-05	0.000342	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—SERPINE1—Behcet's disease	1.45e-05	0.000334	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—NOS3—Behcet's disease	1.39e-05	0.000319	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—CXCL8—Behcet's disease	1.38e-05	0.000316	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—CXCL8—Behcet's disease	1.35e-05	0.000311	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—CXCL8—Behcet's disease	1.33e-05	0.000304	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—CXCL8—Behcet's disease	1.23e-05	0.000283	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—CAT—Behcet's disease	1.22e-05	0.000279	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—APOA1—Behcet's disease	1.21e-05	0.000277	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—APOB—Behcet's disease	1.18e-05	0.000271	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—NOS3—Behcet's disease	1.15e-05	0.000263	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—APOA1—Behcet's disease	9.33e-06	0.000214	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—NOS3—Behcet's disease	9.17e-06	0.00021	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—NOS3—Behcet's disease	7.07e-06	0.000162	CbGpPWpGaD
